Docstoc

Sanofi Appoints David Meeker Chief Executive Officer of Genzyme

Document Sample
Sanofi Appoints David Meeker Chief Executive Officer of Genzyme Powered By Docstoc
					Sanofi Appoints David Meeker Chief Executive
Officer of Genzyme
October 24, 2011 10:33 AM Eastern Daylight Time 

PARIS--(EON: Enhanced Online News)--Sanofi (EURONEXT: SAN and NYSE: SNY) announced today the
appointment of David Meeker as Chief Executive Officer of Genzyme, a Sanofi company, effective November
1, 2011. He will report to Christopher A. Viehbacher, Chief Executive Officer of Sanofi, and will join the Group
Management Committee. Christopher A. Viehbacher will retain the position of Chairman, Genzyme.

“After working closely with David over the past six months, I am confident that he is the best person to lead
Genzyme,” said Christopher A. Viehbacher, Chief Executive Officer of Sanofi. “David’s commitment to
employees, physicians and patients has been a key success factor in the successful integration of Genzyme as
part of the Sanofi Group.His combination of medical and business experience will be essential to move
Genzyme’s broad portfolio of products forward and deliver much-needed therapies to patients.”

Under David Meeker’s leadership, Genzyme will incorporate the Rare Disease business and the Multiple Sclerosis
franchise. Previous Genzyme divisions - Renal, Biosurgery and Oncology - have been integrated within the existing
Sanofi portfolio giving them greater global scale and capabilities.

David joined Genzyme in 1994 as Medical Director to work on the Cystic Fibrosis Gene Therapy program. Over
the years he has held key positions of increasing responsibility as he led the development of treatments in the current
rare disease portfolio. As President of the Global Rare Disease Business, he oversaw the global launches of
Aldurazyme®, Fabrazyme® and Myozyme®. In 2009, he was promoted to Chief Operating Officer of Genzyme and
has played an important role in the integration since April of this year. David received his M.D. from the University of
Vermont Medical School, and completed the Advanced Management Program at Harvard Business School in 2000.

About Sanofi

Sanofi, a global and diversified healthcare leader, discovers, develops and distributes therapeutic solutions focused
on patients’ needs. Sanofi has core strengths in the field of healthcare with seven growth platforms: diabetes
solutions, human vaccines, innovative drugs, rare diseases, consumer healthcare, emerging markets and animal
health. Sanofi is listed in Paris (EURONEXT: SAN) and in New York (NYSE: SNY).

Contacts
Sanofi
Media Relations
Jean-Marc Podvin, +33-1-53-77-46-46
mr@sanofi.com
or
Investor Relations
Sébastien Martel, +33-1-53-77-45-45
ir@sanofi.com
or
Genzyme Media Relations
Bo Piela, +1-617-768-6579
bo.piela@genzyme.com
Recent Stories from Genzyme


  l

      Genzyme Announces Winners of Patient Advocacy Leadership Awards
      August 17, 2011
      CAMBRIDGE, Mass.--(EON: Enhanced Online News)--Genzyme announces the first recipients of the PAL
      Awards, a global grant program that supports non-profit organizations that work on behalf of patient... more »
  l   Genzyme and Isis Announce Submission of European Marketing Authorization Application for Mipomersen
      (Kynamro®)
      July 28, 2011
      CAMBRIDGE, Mass. & CARLSBAD, Calif.--(EON: Enhanced Online News)--Genzyme has submitted a
      marketing authorization application to the European Medicines Agency seeking approval for the 200 mg
      weekly... more »



  l

      Sanofi Reports Positive Top-Line Results from First Phase 3 Study of Alemtuzumab (Lemtrada™ (*)) in 
      Multiple Sclerosis
      July 11, 2011
      PARIS--(EON: Enhanced Online News)--Genzyme announced today positive top-line results from CARE-
      MS I. more »

				
DOCUMENT INFO
Shared By:
Tags:
Stats:
views:13
posted:10/24/2011
language:English
pages:2
Description: PARIS--(EON: Enhanced Online News)--Sanofi announced today the appointment of David Meeker as Chief Executive Officer of Genzyme, a Sanofi company, effective November 1, 2011. img border='0' title='Add to Google' alt='Add to Google' src='http://images.pheedo.com/images/mm/google.p
EON: Enhanced Online News EON: Enhanced Online News http://eon.businesswire.com
About At EON: Enhanced Online News, we show you how to make your online press release thrive. If you want to drive traffic to your website, generate sales leads, make an announcement, or promote a new product, EON: Enhanced Online News delivers the online visibility that you need. EON: Enhanced Online News powered by Business Wire.